As biomedical research is strangled, pharma leaders have decided to bend the knee, you know, for the shareholders. Basic research is the foundation that drives industry drug discovery. Pharma is paying fealty just to knee cap itself when basic research has withered away. https://endpts.com/pfizer-ceo-says-trump-opportunities-outweigh-risks/